blood coagulation disease: A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
184 |
4. Check minimum number of eventsNone |
184 |
5. Include endpoints |
913 |
6. Filter based on genotype QC (FinnGen only) |
913 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF2
Chronic Coagulation defects
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6363 | 4116 | 2218 |
| Only index persons | 5866 | 3942 | 1924 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.12 | 0.06 |
| Only index persons | 0.12 | 0.14 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 29.42 | 33.02 | 22.61 |
| Only index persons | 29.70 | 32.84 | 23.25 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 913 | 690 | 223 |
| Unadjusted period prevalence (%) | 0.20 | 0.24 | 0.10 |
| Median age at first event (years) | 37.68 | 35.84 | 43.39 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 822
- Matched controls
- 8218
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D68.0
ICD-10 Finland
Von Willebrand disease
+∞
323.0
429
*
D68.2
ICD-10 Finland
Hereditary deficiency of other clotting factors
+∞
321.6
287
*
126
Kela drug reimbursment
Chronic coagulation defects
+∞
178.8
165
*
B02AA02
ATC
tranexamic acid; systemic
9.5
168.3
428
842
D68.8
ICD-10 Finland
Other specified coagulation defects
47.1
123.7
151
39
D66
ICD-10 Finland
Hereditary factor VIII deficiency
+∞
86.0
81
*
D68.9
ICD-10 Finland
Coagulation defect, unspecified
157.5
69.1
72
5
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
30.8
67.9
91
33
B02BD02
ATC
coagulation factor VIII; parenteral, topical, urethral
+∞
35.7
34
*
2864A
ICD-9 Finland
Coagulation defects, von Willebrand's disease
+∞
34.6
33
*
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
46.6
33.1
40
9
B01AB04
ATC
dalteparin; parenteral
6.6
29.9
80
133
N02AX02
ATC
tramadol; systemic, rectal
2.4
29.7
373
2117
B01AA03
ATC
warfarin; systemic
3.4
29.6
159
535
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.1
26.3
86
183
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
3.2
26.0
152
542
B01AB05
ATC
enoxaparin; parenteral
2.4
25.2
268
1369
28630
ICD-8 Finland
Coagulation defects, Vascular haemophilia
+∞
25.1
24
*
EBA10
NOMESCO Finland
Surgical removal of tooth
2.9
24.7
175
707
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
6.7
24.6
64
102
N02BE01
ATC
paracetamol; systemic, rectal
2.6
23.3
714
5869
2860A
ICD-9 Finland
Coagulation defects, Congenital factor VIII disorder
+∞
22.0
21
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
4.0
21.1
88
238
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
7.8
20.7
48
65
D67
ICD-10 Finland
Hereditary factor IX deficiency
+∞
19.9
19
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
18.9
350
2225
M362, D66
ICD-10 Finland
NA
+∞
18.8
18
*
28600
ICD-8 Finland
Coagulation defects, Haemophilia
+∞
18.8
18
*
R04.0
ICD-10 Finland
Epistaxis
4.3
18.7
71
176
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
21.4
18.7
27
13
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
18.1
394
2651
M01AE01
ATC
ibuprofen; systemic, rectal
0.5
16.0
561
6663
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
15.6
300
1897
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
15.6
316
2037
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
15.5
296
1866
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
15.4
227
1298
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
2.5
15.4
131
579
R42
ICD-10 Finland
Dizziness and giddiness
2.2
14.6
171
882
D68.4
ICD-10 Finland
Acquired coagulation factor deficiency
+∞
14.6
14
*
M36.2
ICD-10 Finland
Haemophilic arthropathy
+∞
14.6
14
*
D69.1
ICD-10 Finland
Qualitative platelet defects
152.6
14.5
15
*
O28.0
ICD-10 Finland
Abnormal haematological finding on antenatal screening of mother
36.7
14.5
18
5
H02AB06
ATC
prednisolone; systemic
1.8
14.4
371
2576
ZX120
NOMESCO Finland
Intravenous
2.8
14.0
93
357
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
13.8
102
416
D68.1
ICD-10 Finland
Hereditary factor XI deficiency
+∞
13.6
13
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
13.2
230
1386
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
12.8
166
891
M79.6
ICD-10 Finland
Pain in limb
1.8
12.8
298
1981
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
8.0
12.7
28
36
ZXE00
NOMESCO Finland
One hour or less
1.7
12.6
344
2399
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
12.5
123
583
2BD06
NOMESCO Finland
NA
131.9
12.5
13
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
12.3
77
285
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.1
12.3
70
243
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
12.0
297
2000
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
12.0
227
1403
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
12.0
340
2389
R03AC02
ATC
salbutamol; inhalant
1.7
11.9
443
3366
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.9
11.9
196
1155
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
11.8
267
1746
R06.0
ICD-10 Finland
Dyspnoea
1.9
11.8
184
1059
J01DB01
ATC
cefalexin; oral
1.9
11.8
671
5781
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
11.6
119
574
R51.80
ICD-10 Finland
Headache
2.1
11.5
151
811
AA1AD
NOMESCO Finland
CT of head and brain
2.0
11.4
160
885
UJF32
NOMESCO Finland
Coloscopy
1.9
11.3
187
1098
Z31.5
ICD-10 Finland
Genetic counselling
2.9
11.3
70
257
N03AX16
ATC
pregabalin; oral
1.9
11.3
183
1067
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.5
11.2
90
384
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
5.0
11.1
35
73
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
11.1
219
1366
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
11.0
142
757
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
10.9
438
3367
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
10.5
182
1081
194
Kela drug reimbursment
Blood coagulation factor VIII and von Willebrand factor for the treatment of von Willebrand disease
+∞
10.4
10
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
10.4
181
1081
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
10.2
178
1060
N03AX12
ATC
gabapentin; oral
2.1
9.9
123
646
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
9.7
9.8
19
20
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
9.7
78
335
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
9.5
216
1401
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.3
9.4
24
39
B02BD06
ATC
von Willebrand factor and coagulation factor VIII in combination; parenteral, topical, urethral
+∞
9.4
9
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.2
9.4
48
156
Z71.8
ICD-10 Finland
Other specified counselling
1.7
9.4
209
1347
9981A
ICD-9 Finland
Other complications of procedures, not elsewhere classified, Haemorrhage or haematoma complicating a procedure
13.9
9.2
15
11
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.9
9.2
150
872
B18.2
ICD-10 Finland
Chronic viral hepatitis C
6.8
9.2
22
33
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
15.8
9.1
14
9
I80.20
ICD-10 Finland
Phlebitis and thrombophlebitis in the iliac vein
24.3
8.9
12
5
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
8.9
299
2155
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
4.4
8.9
31
73
Z3231
NOMESCO Finland
Registered nurse
1.7
8.9
212
1393
J01DA01
ATC
[U] cefalexin; systemic
1.6
8.9
499
4079
Z83.2
ICD-10 Finland
Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
50.5
8.7
10
*
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
50.5
8.7
10
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.4
8.6
74
329
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
8.5
145
855
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
8.3
341
2571
G43.9
ICD-10 Finland
Migraine, unspecified
2.3
8.3
77
355
K94
ICPC
Phlebitis/thrombophlebitis
6.6
8.2
20
31
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
14.6
8.2
13
9
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
8.2
79
371
ZXD05
NOMESCO Finland
Urgent procedure
1.6
8.1
252
1772
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
8.1
55
215
P01AB01
ATC
metronidazole; oral, rectal
1.6
8.1
322
2404
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
8.0
149
904
G47.3
ICD-10 Finland
Sleep apnoea
1.8
7.9
140
834
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.2
7.9
77
364
J01FF01
ATC
clindamycin; systemic
1.6
7.8
210
1417
LCA06
NOMESCO Finland
Biopsy of endometrium
1.9
7.7
112
625
M25.5
ICD-10 Finland
Pain in joint
1.6
7.6
234
1638
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
2.8
7.6
48
180
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
7.5
94
494
J01CA04
ATC
amoxicillin; systemic
1.6
7.5
671
5994
D86.0
ICD-10 Finland
Sarcoidosis of lung
6.5
7.4
18
28
B28
ICPC
Limited function/disability (B)
80.8
7.4
8
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.7
7.4
20
36
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
7.4
57
238
K92.1
ICD-10 Finland
Melaena
3.2
7.4
37
120
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.4
7.4
63
279
A02BC02
ATC
pantoprazole; systemic
1.5
7.4
458
3754
K01.0
ICD-10 Finland
Embedded teeth
3.8
7.3
29
78
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
7.3
113
644
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
7.3
268
1953
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
7.3
58
249
28610
ICD-8 Finland
Coagulation defects, Christmas disease
+∞
7.3
7
*
B02BD04
ATC
coagulation factor IX; parenteral
+∞
7.3
7
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.6
7.3
31
89
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
7.2
139
849
M25.0
ICD-10 Finland
Haemarthrosis
7.4
7.2
16
22
K08.3
ICD-10 Finland
Retained dental root
2.5
7.2
53
217
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.7
7.2
46
174
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
3.5
7.2
32
95
J01FA10
ATC
azithromycin; systemic
1.5
7.2
496
4148
I87.0
ICD-10 Finland
Postthrombotic syndrome
20.2
7.1
10
5
M01AG02
ATC
tolfenamic acid; oral, rectal
1.7
7.1
146
910
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
7.1
184
1226
R50.9
ICD-10 Finland
Fever, unspecified
1.9
7.0
110
627
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
7.0
396
3166
ZXA10
NOMESCO Finland
Bilateral
1.8
7.0
129
780
SPAT1263
SPAT
Sampling
1.5
7.0
332
2559
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.5
7.0
52
216
R55
ICD-10 Finland
Syncope and collapse
2.1
6.9
72
352
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.9
6.8
39
137
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.2
6.8
71
346
N02AA05
ATC
oxycodone; systemic
2.0
6.7
82
429
N03AF01
ATC
carbamazepine; oral, rectal
2.9
6.7
39
140
G50.0
ICD-10 Finland
Trigeminal neuralgia
5.6
6.6
18
33
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.9
6.6
93
512
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.8
6.6
26
70
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
6.6
81
423
C01CA24
ATC
epinephrine; parenteral
2.1
6.6
68
331
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
6.6
127
778
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.6
255
1876
O80.8
ICD-10 Finland
Other single spontaneous delivery
2.5
6.5
47
192
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
6.5
101
574
R01AD12
ATC
fluticasone furoate; nasal
1.5
6.5
263
1948
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
6.5
80
419
R4110
NOMESCO Finland
Physiotherapy
1.6
6.5
189
1297
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
6.5
104
600
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.2
6.4
64
304
C03CA01
ATC
furosemide; systemic
1.7
6.4
135
848
3AC01
NOMESCO Finland
NA
6.0
6.3
16
27
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
11.1
6.3
11
10
R60.0
ICD-10 Finland
Localized oedema
2.1
6.3
72
364
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
6.3
56
255
O991, D680
ICD-10 Finland
NA
+∞
6.3
6
*
2BDXX
NOMESCO Finland
NA
+∞
6.3
6
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
6.2
142
915
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
6.3
6.2
15
24
C07AB07
ATC
bisoprolol; oral
1.5
6.2
264
1978
R31
ICD-10 Finland
Unspecified haematuria
2.2
6.1
56
259
N02AC04
ATC
dextropropoxyphene; oral
3.7
6.1
25
70
R23.3
ICD-10 Finland
Spontaneous ecchymoses
3.9
6.1
23
60
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
6.1
135
861
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
6.8
6.1
14
21
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
6.0
69
352
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
6.0
90
507
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
380
225
28.22
307.65
7.3
3.1
%
113.4
171.6
18.97
359
216
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
275
226
16.98
291.01
4.5
3.3
g/l
3.1
3.6
3.35
254
213
(3036489) Thrombin time
269
286
12.92
239.87
4.8
2.7
s
21.8
21.2
0.41
222
250
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
121
26
53.50
209.80
1.6
1.0
%
100.2
129.4
2.39
109
26
(3018677) aPTT in Platelet poor plasma by Coagulation assay
422
944
7.45
198.38
4.4
2.2
s
32.5
29.6
5.22
405
911
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
106
26
45.99
177.89
1.4
1.0
%
94.3
98.9
0.23
57
16
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
105
27
43.81
174.13
1.3
1.0
%
95.4
94.6
0.05
54
17
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
200
259
9.61
150.83
5.4
3.0
%
96.3
93.7
0.81
195
238
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
96
8
133.89
90.91
1.7
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
433
1756
3.79
85.08
7.3
3.6
%
93.0
94.8
0.58
416
1700
(3012095) Magnesium [Moles/volume] in Serum or Plasma
303
1025
3.93
76.70
5.0
3.8
mmol/l
0.8
0.8
0.34
295
965
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
399
1713
3.36
68.52
3.7
1.9
mg/l
0.8
0.9
1.12
292
1271
(3032080) INR in Blood by Coagulation assay
465
2377
2.95
56.09
13.9
7.2
inr
1.3
1.1
2.27
163
749
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
234
867
3.28
48.97
4.1
2.4
%
23.6
23.4
0.05
221
738
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
177
550
3.75
48.77
3.0
2.4
ml/min/173m2
83.6
73.8
3.12
135
216
(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay
46
0
+∞
48.36
1.5
0.0
%
51.1
—
—
40
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
484
2778
2.58
42.94
6.2
4.7
g/l
37.0
36.4
1.39
449
2608
(3004789) Transferrin [Mass/volume] in Serum or Plasma
238
955
3.02
42.86
4.0
2.3
g/l
2.4
2.4
0.23
226
875
(3022948) Iron [Moles/volume] in Serum or Plasma
249
1051
2.88
40.66
3.9
2.3
umol/l
14.1
13.9
0.18
238
964
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
253
1133
2.71
36.40
3.8
2.6
mmol/l
2.4
2.4
1.74
238
994
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
172
625
3.16
36.33
3.4
4.5
u/l
225.7
248.9
0.74
162
595
(3015377) Calcium [Moles/volume] in Serum or Plasma
400
2284
2.34
33.49
3.7
3.2
mmol/l
2.4
2.4
0.08
365
2035
(3006315) Basophils [#/volume] in Blood
569
3782
2.34
33.06
6.9
5.8
e9/l
0.0
0.0
1.40
514
3298
(3001604) Monocytes [#/volume] in Blood
566
3763
2.33
32.73
6.9
5.8
e9/l
0.5
0.5
0.32
513
3287
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
332
1767
2.38
32.50
3.5
2.2
mg/l
2.8
2.9
0.04
289
1518
(3027945) Reticulocytes/100 erythrocytes in Blood
166
628
3.01
32.47
3.4
3.0
%
1.7
1.8
0.28
150
564
(3013115) Eosinophils [#/volume] in Blood
581
3916
2.33
32.36
7.1
6.2
e9/l
0.2
0.2
0.42
526
3472
(3019198) Lymphocytes [#/volume] in Blood
575
3887
2.29
31.39
6.9
5.9
e9/l
1.9
2.0
0.02
520
3469
(42870588) Differential panel, method unspecified - Blood
408
2423
2.24
30.30
6.5
5.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
504
3262
2.22
30.15
7.7
6.6
mmol/l
1.2
1.2
0.16
424
2783
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
462
2916
2.18
29.10
8.4
5.9
mmol/l
1.2
1.2
0.04
430
2659
(3006504) Eosinophils/100 leukocytes in Blood
531
3548
2.19
28.81
7.0
5.8
%
2.6
2.8
1.53
503
3313
(3022096) Basophils/100 leukocytes in Blood
517
3433
2.17
28.32
7.1
5.8
%
0.7
0.7
0.10
492
3210
(3019069) Monocytes/100 leukocytes in Blood
531
3571
2.16
28.04
7.2
6.0
%
8.0
8.2
0.78
507
3365
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
718
5488
2.44
27.19
8.5
6.9
u/l
74.7
76.9
0.78
686
5157
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
524
3564
2.10
26.13
6.2
5.9
umol/l
10.3
10.7
0.24
499
3373
(3013650) Neutrophils [#/volume] in Blood by Automated count
604
4348
2.15
25.73
9.3
8.8
e9/l
4.0
4.0
0.30
554
3820
(3002030) Lymphocytes/100 leukocytes in Blood
534
3690
2.08
25.12
7.1
5.8
%
28.6
29.2
0.61
509
3465
(3018010) Neutrophils/100 leukocytes in Blood
527
3648
2.05
24.38
6.8
5.6
%
57.0
56.6
0.40
504
3433
(3018418) pH of Serum or Plasma
328
1922
2.10
23.86
4.8
3.6
ph
7.4
7.4
0.08
79
347
(3021589) Normoblasts [#/volume] in Blood
498
3398
2.02
23.74
11.7
8.4
e9/l
0.0
0.0
0.83
422
2780
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
157
4.24
23.16
5.7
4.2
u/ml
0.3
0.4
0.83
39
78
(3013826) Glucose [Moles/volume] in Serum or Plasma
545
3972
1.92
20.02
6.1
4.6
mmol/l
6.4
6.5
0.68
521
3637
(40758558) Short blood count panel - Blood
309
1888
1.96
19.18
6.4
6.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
688
5489
2.03
18.59
5.0
3.9
mm/h
9.7
10.5
0.94
658
5123
(3001122) Ferritin [Mass/volume] in Serum or Plasma
522
3808
1.87
18.50
4.5
2.8
ug/l
92.0
88.8
0.18
493
3577
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
52
140
3.88
17.21
1.4
1.2
u/ml
4.3
5.6
0.26
26
57
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
51
139
3.83
16.59
1.4
1.2
u/ml
2.8
3.2
0.08
17
48
(3018095) Leukocytes [#/volume] in Urine
363
2464
1.79
15.41
3.7
3.4
e6/l
42.6
70.5
0.97
269
1634
(3000850) Epithelial cells [#/volume] in Urine
231
1363
1.93
15.37
2.6
2.5
e6/l
6.2
7.1
0.33
202
1183
(3002582) Erythrocytes [#/volume] in Urine
310
2017
1.81
15.11
3.3
3.0
e6/l
27.8
85.7
1.00
249
1502
(3022217) INR in Platelet poor plasma by Coagulation assay
131
630
2.26
15.06
31.7
17.0
inr
1.5
1.2
—
10
102
(3030467) Casts [#/volume] in Urine by Automated count
286
1826
1.82
14.78
3.2
2.8
e6/l
0.3
0.4
0.43
230
1323
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
14
0
+∞
14.62
2.5
0.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
102
447
2.44
14.48
3.4
3.0
e9/l
76.9
70.1
1.04
68
337
(3034426) Prothrombin time (PT)
20
26
7.84
14.47
1.1
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
112
515
2.34
14.27
4.6
4.5
%
0.3
0.9
0.34
24
122
(4268621)
37
89
4.29
14.24
2.6
2.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
280
1798
1.80
14.08
3.2
2.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
46
132
3.62
13.91
1.2
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
214
1287
1.87
13.20
2.6
2.6
mosm/kgh2o
528.4
543.8
0.42
182
1081
(3002179) Metamyelocytes/100 leukocytes in Blood
111
528
2.25
13.04
3.9
4.2
%
0.8
0.6
0.27
21
115
(3037522) Nuclear Ab [Titer] in Serum
191
1115
1.90
12.89
1.5
1.3
titre
900.0
547.2
0.71
32
231
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
464
3490
1.67
12.84
5.3
3.9
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
12
0
+∞
12.53
1.4
0.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
117
578
2.17
12.52
4.5
4.3
%
1.2
1.0
0.29
29
163
(3023103) Potassium [Moles/volume] in Serum or Plasma
842
7561
2.46
12.50
19.1
12.6
mmol/l
3.9
3.9
2.34
831
7354
(3019550) Sodium [Moles/volume] in Serum or Plasma
840
7536
2.43
12.48
19.3
12.6
mmol/l
139.6
139.6
0.30
831
7349
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
849
7656
2.55
12.41
17.9
11.6
mg/l
19.1
20.9
0.86
722
5891
(40760892) CBC W Ordered Manual Differential panel - Blood
276
1820
1.74
12.40
4.9
4.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
112
548
2.19
12.27
4.5
4.4
%
0.1
0.1
0.09
24
147
(4306422)
41
122
3.47
11.76
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
257
1707
1.70
11.05
3.0
2.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
322
2270
1.65
11.01
3.4
2.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
102
504
2.15
10.88
5.9
3.3
mmol/l
1.2
1.2
0.36
94
429
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
346
2517
1.60
10.25
3.5
3.2
u/l
26.9
29.5
1.59
330
2403
(3001186) Copper [Moles/volume] in Serum or Plasma
11
10
11.12
10.18
1.2
1.1
umol/l
14.9
18.8
—
11
10
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
15
21
7.25
10.16
2.6
2.0
ug/l
51.2
76.6
0.53
15
21
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
406
3118
1.54
9.23
2.9
2.3
nmol/l
74.8
75.2
0.10
384
2856
(3002385) Erythrocyte distribution width [Ratio]
752
6652
1.74
9.20
22.1
14.2
%
13.7
13.5
1.32
744
6531
(3037467) Urinalysis macro (dipstick) panel - Urine
610
5142
1.56
8.91
4.8
4.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
299
2159
1.57
8.86
2.5
2.4
u/l
53.8
55.6
0.52
283
2007
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
322
2365
1.56
8.85
3.2
3.2
ng/l
20.7
50.4
0.98
173
1351
(3005719) IgG [Mass/volume] in Serum or Plasma
106
574
1.96
8.80
2.7
2.8
g/l
9.4
10.3
1.93
99
528
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
220
1479
1.64
8.76
2.8
3.1
ng/l
1274.0
1042.9
0.38
176
1219
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
181
1158
1.70
8.71
3.7
3.3
ng/l
402.9
342.3
0.12
120
757
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
777
6967
1.77
8.68
15.7
10.1
ml/min/173m2
89.0
87.8
0.82
691
5649
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
202
1339
1.65
8.48
1.3
1.3
u/ml
33.3
13.3
0.47
80
560
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
208
1398
1.63
8.24
1.4
1.3
iu/ml
27.9
28.6
0.03
60
460
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
343
2613
1.50
7.72
2.0
1.9
pmol/l
101.0
96.9
0.78
197
1397
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
259
1862
1.55
7.63
1.7
1.7
mmol/l
1.5
1.4
1.08
226
1614
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
57
258
2.29
7.54
1.5
2.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
863
8075
2.26
7.52
17.6
11.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
226
1596
1.55
7.16
5.1
3.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
860
8056
2.16
7.14
13.1
9.2
u/l
25.2
25.3
0.08
847
7830
(3036481) Cortisol [Moles/volume] in Serum or Plasma
120
722
1.76
7.13
2.4
2.0
nmol/l
359.2
373.0
0.39
112
669
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
21
56
3.81
7.11
1.2
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
133
828
1.71
7.00
8.8
6.1
mmol/l
1.1
1.1
0.07
127
768
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
154
997
1.66
6.99
2.1
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
164
1084
1.63
6.86
2.1
2.5
ug/g
88.1
103.7
0.46
122
861
(3031040) Bacteria [#/volume] in Urine by Automated count
572
4889
1.46
6.77
5.1
4.1
e6/l
158.5
1317.4
—
10
63
(3005322) IgE [Units/volume] in Serum or Plasma
98
566
1.82
6.67
1.4
1.2
u/ml
73.9
200.8
2.11
89
519
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
29
4.89
6.47
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
21
60
3.56
6.46
1.1
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
18
6.17
6.44
1.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
134
857
1.66
6.36
2.0
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
109
659
1.74
6.36
4.2
3.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
111
675
1.73
6.35
2.0
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
449
3700
1.42
6.30
4.1
3.3
estimate
0.0
0.0
0.00
117
707
(3026493) Urate [Moles/volume] in Serum or Plasma
232
1689
1.50
6.28
3.2
2.5
umol/l
1764.8
5733.7
1.53
206
1490
(3010421) pH of Blood
37
150
2.53
6.26
4.9
2.5
ph
7.4
7.4
0.57
32
121
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
54
259
2.15
6.25
1.6
1.6
g/l
0.2
0.2
0.89
54
243
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
691
6172
1.49
6.17
5.2
4.1
pmol/l
14.5
14.5
0.21
655
5754
(3029937) Albumin [Presence] in Urine by Test strip
262
1961
1.47
6.17
4.7
3.6
estimate
0.0
0.0
1.34
122
709
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
109
666
1.72
6.13
1.9
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
104
628
1.74
6.09
3.4
3.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
32
123
2.66
6.02
5.3
2.5
mmol/l
2.8
2.3
0.37
21
76
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
55
272
2.09
5.90
1.6
1.5
g/l
1.1
1.2
0.79
55
254
(3028026) IgM [Mass/volume] in Serum or Plasma
80
453
1.84
5.81
1.9
1.8
g/l
1.1
1.3
1.29
75
418
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
28
4.70
5.75
1.1
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
160
1097
1.56
5.68
2.8
2.4
e6/l
0.6
1.0
2.12
93
599
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
153
1039
1.57
5.66
2.9
2.6
e6/l
2.9
3.2
0.20
86
545
(3011412) CD3 cells [#/volume] in Blood
22
71
3.15
5.64
2.0
2.5
e9/l
1.3
1.3
0.01
12
39
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
124
802
1.63
5.62
4.1
3.0
umol/l
8.9
7.6
0.15
106
693
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
250
1889
1.45
5.51
2.4
2.1
u/l
175.2
248.6
0.52
242
1785
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
141
2.47
5.51
3.6
3.6
%
58.4
56.5
0.34
34
141
(3007164) IgA [Mass/volume] in Serum or Plasma
232
1731
1.46
5.46
1.8
1.5
g/l
2.1
2.2
0.07
153
1076
(3030905) Polymorphonuclear cells [#/volume] in Blood
33
137
2.46
5.35
3.1
3.4
e9/l
4.3
4.2
0.11
33
137
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
261
2005
1.42
5.22
1.4
1.3
u/ml
0.6
1.8
3.01
84
536
(3003396) Base excess in Arterial blood by calculation
99
616
1.68
5.21
11.1
9.1
mmol/l
0.9
1.2
0.28
79
486
(40767503) Oxygen content in Capillary blood by calculation
28
109
2.62
5.17
3.8
2.3
%
17.3
16.2
0.56
13
57
(3027135) IgG subclass 1 [Mass/volume] in Serum
22
75
2.98
5.17
1.7
1.3
g/l
5.9
6.9
0.72
17
57
(3024139) IgG subclass 3 [Mass/volume] in Serum
22
75
2.98
5.17
1.7
1.3
g/l
0.3
0.4
0.33
17
56
(3028192) IgG subclass 2 [Mass/volume] in Serum
22
75
2.98
5.17
1.7
1.3
g/l
2.7
2.5
0.15
15
56
(3024980) IgG subclass 4 [Mass/volume] in Serum
30
121
2.53
5.17
1.7
1.8
g/l
0.5
0.8
1.35
24
96
(3009261) Glucose [Presence] in Urine by Test strip
446
3761
1.36
5.04
4.1
3.3
estimate
0.0
0.0
0.80
120
698
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
91
562
1.69
4.93
3.3
3.5
pmol/l
4.5
4.6
0.35
81
492
(3020961) Endomysium IgA Ab [Titer] in Serum
79
469
1.75
4.93
1.2
1.1
titre
—
124.5
—
0
10
(3042936) Bacteria identified in Isolate by Culture
140
961
1.54
4.92
2.4
2.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
20
67
3.03
4.85
1.7
2.1
e6/l
691.2
727.3
—
9
23
(4062490)
22
78
2.87
4.84
1.7
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
74
436
1.76
4.75
1.7
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
39
185
2.16
4.70
2.5
3.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
439
3720
1.35
4.68
5.4
4.5
estimate
0.0
0.0
0.50
123
715
(3000991) Gas panel - Venous blood
81
493
1.71
4.64
9.6
8.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
115
774
1.56
4.41
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
57
319
1.84
4.35
1.7
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
13
36
3.65
4.21
1.1
1.1
miu/ml
1852.1
1589.4
0.36
13
36
(3020630) Protein [Mass/volume] in Serum or Plasma
75
460
1.69
4.19
2.7
2.9
g/l
66.7
67.2
0.28
69
422
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
45
237
1.95
4.13
1.2
1.2
u/ml
45.0
15.1
—
5
13
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
42
216
1.99
4.12
1.2
1.2
u/ml
4.3
2.9
—
6
24
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
767
7163
1.44
3.99
6.0
4.8
mu/l
1.8
2.0
0.52
724
6729
(40768804) Tissue Pathology biopsy report
366
3072
1.32
3.97
2.2
2.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
42
220
1.95
3.93
1.2
1.3
u/ml
3.0
13.9
—
8
40
(40768443) Skin Pathology biopsy report
50
278
1.84
3.92
1.2
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
97
646
1.56
3.91
2.4
2.4
u/l
236.7
108.3
0.25
87
540
(40768797) Stomach Pathology biopsy report
134
956
1.47
3.91
1.3
1.2
—
—
—
0
0
(3019225) pH of Specimen
93
616
1.57
3.84
4.2
3.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
44
237
1.90
3.80
1.5
2.1
g/l
1.4
1.4
0.21
38
208
(3004588) Protein electrophoresis panel - Serum or Plasma
63
379
1.71
3.80
2.9
2.3
—
—
—
0
0
(3044889) 12 lead EKG panel
547
4870
1.31
3.78
3.5
3.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
18
66
2.76
3.77
1.9
1.7
pg
33.6
32.2
0.86
18
66
(3026008) Bacteria identified in Urine by Culture
261
2101
1.34
3.75
3.0
2.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
652
5956
1.33
3.69
3.8
3.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
83
541
1.59
3.68
2.2
2.2
u/l
3064.5
4154.5
0.22
30
224
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
67
414
1.67
3.67
2.9
3.0
ng/l
190.0
146.4
0.37
61
379
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
345
2898
1.31
3.65
4.4
3.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
888
8612
2.14
3.60
27.9
17.3
e9/l
257.8
260.0
0.42
882
8428
(3002256) Pathology report gross observation
128
923
1.45
3.54
1.3
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
247
1987
1.33
3.54
3.4
3.2
mmol/l
7.6
7.8
0.26
210
1714
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
37
193
1.96
3.53
1.2
1.2
u/ml
50.1
27.0
—
6
18
(3048929) Epstein Barr virus Ab [Presence] in Serum
53
311
1.75
3.51
1.5
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
15
52
2.92
3.47
1.5
2.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
888
8620
2.10
3.46
27.9
17.3
e12/l
4.5
4.5
0.11
882
8423
(21494755) Public health laboratory ask at order entry panel
64
991
0.62
3.42
1.3
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
888
8622
2.09
3.42
28.0
17.3
e9/l
6.8
6.7
1.69
881
8414
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
26
120
2.20
3.41
4.3
2.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
34
175
1.98
3.37
1.8
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
18
5.04
3.37
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
263
2148
1.32
3.37
3.6
2.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
53
315
1.72
3.36
5.4
4.8
mmol/l
24.2
23.8
0.32
48
294
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
30
149
2.05
3.28
1.2
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
38
3.19
3.22
2.8
4.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
56
345
1.66
3.13
10.5
7.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
577
5243
1.27
3.07
3.6
3.0
u/l
44.1
40.3
0.58
541
5004
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
286
1.72
3.04
10.3
13.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
72
476
1.56
3.04
1.3
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
21
4.32
3.00
2.9
3.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
20
88
2.30
2.95
1.5
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
20
88
2.30
2.95
2.4
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
22
4.12
2.88
1.7
2.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
53
2.67
2.80
1.6
2.4
%
8.9
11.2
—
7
37
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
19
84
2.29
2.78
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
41
240
1.74
2.78
1.9
1.9
iu/l
2.6
5.1
2.74
17
90
(40761535) Cells panel - Urine sediment
76
520
1.50
2.76
4.7
3.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
77
529
1.50
2.74
4.0
4.0
ng/l
89.4
74.7
0.54
69
479
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
30
160
1.90
2.74
1.7
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
206
1670
1.30
2.73
4.0
3.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
31
168
1.87
2.70
1.5
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
772
7330
1.34
2.67
4.6
3.9
mmol/l
4.7
4.8
0.96
725
6921
(3029075) Extractable nuclear Ab panel - Serum
10
32
3.15
2.65
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
30
162
1.88
2.65
1.5
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
23
113
2.06
2.63
1.6
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
235
1947
1.28
2.63
1.8
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
60
396
1.55
2.58
1.8
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
25
3.63
2.58
2.4
2.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
27
142
1.93
2.58
1.4
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
58
381
1.56
2.55
1.7
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
7
7.18
2.55
1.6
1.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
11
5.48
2.54
2.5
2.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
22
108
2.06
2.53
4.5
4.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
22
108
2.06
2.53
1.4
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
25
129
1.96
2.52
6.2
2.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
82
2.22
2.48
1.1
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
16
4.40
2.48
2.1
2.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
51
2.57
2.45
1.9
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
219
1.72
2.45
2.8
1.7
g/l
3.4
3.8
1.72
31
161
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
219
1.72
2.45
2.8
1.7
g/l
6.9
7.5
1.42
32
172
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
219
1.72
2.45
2.8
1.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
83
2.19
2.42
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
83
2.19
2.42
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
83
2.19
2.42
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
138
1076
1.33
2.41
1.8
1.7
nmol/l
1147.2
1185.8
0.18
106
826
(3021879) Hepatitis B virus core Ab [Presence] in Serum
89
649
1.41
2.36
1.5
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
93
685
1.40
2.33
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
65
2.33
2.32
1.7
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
15
65
2.33
2.32
17.3
9.3
mmol/l
7.1
6.4
0.37
15
51
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
28
3.24
2.31
1.0
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
30
170
1.79
2.31
1.5
1.3
u/ml
239.3
238.9
0.00
19
101
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
18
85
2.14
2.30
1.2
1.1
g/l
1.3
1.4
0.34
18
77
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
31
178
1.77
2.29
1.5
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
184
1504
1.28
2.28
1.7
1.5
nmol/l
21.6
21.1
0.16
161
1317
(44806118)
18
86
2.12
2.24
1.7
1.5
—
—
—
0
0
(44790049)
18
86
2.12
2.24
1.7
1.5
—
—
—
0
0
(44790048)
18
86
2.12
2.24
1.7
1.5
—
—
—
0
0
(44790047)
18
86
2.12
2.24
1.7
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
28
157
1.81
2.23
1.7
1.8
g/l
0.0
0.0
0.00
28
146
(3017143) Hepatitis C virus Ab [Presence] in Serum
133
1044
1.32
2.23
1.7
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
21
107
1.99
2.22
1.6
1.6
—
—
—
0
0
(3013512) EKG study
209
1742
1.26
2.20
3.3
3.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
122
1.91
2.17
1.5
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
74
2.18
2.15
2.9
3.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
130
1.87
2.14
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
160
1.77
2.11
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
25
3.22
2.10
1.6
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
737
7013
1.26
2.08
4.1
3.5
mmol/l
1.4
1.2
1.92
696
6584
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
82
2.09
2.08
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
82
2.09
2.08
1.1
1.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
9
31
2.92
2.07
42.9
35.5
ug/l
97.0
124.4
—
9
24
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
27
154
1.78
2.06
2.4
2.8
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
20
3.52
2.06
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
20
3.52
2.06
1.0
1.1
%
89.1
96.0
—
7
20
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
763
7295
1.28
2.04
4.5
3.8
mmol/l
1.4
1.5
4.13
717
6862
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
76
2.12
2.03
1.6
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
61
429
1.45
1.99
2.3
2.4
ug/l
6.9
7.0
0.01
53
386
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
59
413
1.46
1.98
6.3
4.2
mmol/l
1.6
1.6
0.00
42
298
(3000570) Elastase.pancreatic [Mass/mass] in Stool
33
202
1.66
1.98
1.6
1.4
ug/g
341.2
309.1
0.35
20
113
(3002032) Base excess in Venous blood by calculation
77
567
1.39
1.96
5.6
4.5
mmol/l
2.3
1.8
0.73
67
445
(3026389) Candida sp identified in Specimen by Organism specific culture
19
98
1.96
1.96
1.4
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
71
516
1.41
1.95
3.0
2.7
e9/l
4.6
4.1
0.72
55
432
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
142
1.78
1.94
1.2
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
11
4.56
1.94
2.6
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
27
2.98
1.94
1.0
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
774
7426
1.28
1.92
4.9
4.2
mmol/l
2.8
2.8
0.44
727
6968
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
26
150
1.75
1.92
1.8
1.5
u/ml
100.4
108.3
—
7
28
(3018405) Lactate [Moles/volume] in Arterial blood
33
204
1.64
1.91
14.3
4.3
mmol/l
1.1
1.3
0.99
33
199
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
19
99
1.94
1.91
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
210
1781
1.23
1.88
4.5
4.1
mg/mmol
11.4
9.6
0.25
142
1133
(3047189) Immunofixation for 24 hour Urine
7
22
3.20
1.88
1.7
2.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
22
3.20
1.88
1.1
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
31
190
1.65
1.86
9.3
4.3
kpa
8.0
8.8
1.41
31
179
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
17
3.55
1.84
1.0
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
130
1.79
1.83
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
130
1.79
1.83
1.3
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
12
4.18
1.82
1.8
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
194
1638
1.23
1.81
1.8
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
53
2.28
1.81
3.1
4.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
29
2.77
1.79
1.0
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
29
2.77
1.79
1.0
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
14
67
2.11
1.76
1.7
1.3
—
—
—
0
0
(4010399)
65
475
1.40
1.75
1.4
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
18
3.35
1.75
2.2
2.2
—
—
—
0
0
(3009343) pH of Capillary blood
59
425
1.42
1.73
6.3
4.2
ph
7.4
7.4
0.75
12
40
(3021901) Oxygen saturation in Capillary blood
19
103
1.86
1.72
3.6
2.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
23
133
1.75
1.71
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
266
2331
1.20
1.70
1.7
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
38
253
1.52
1.65
1.5
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
25
2.81
1.65
1.0
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
25
2.81
1.65
1.1
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
233
2023
1.20
1.65
2.1
1.9
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
49
2.26
1.64
1.8
1.4
ug/l
13.9
23.5
1.25
11
49
(3000494) Fungus identified in Specimen by Culture
107
854
1.29
1.62
1.5
1.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
128
1.74
1.61
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
113
1.79
1.61
1.2
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
46
321
1.46
1.61
1.9
1.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
84
1.92
1.60
1.1
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
70
2.02
1.59
1.3
1.2
u/ml
0.3
0.1
—
8
24
(3005011) Chlamydia sp Ab [Titer] in Serum
6
20
3.01
1.58
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
43
298
1.46
1.56
2.0
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
198
1701
1.21
1.56
3.4
3.3
mg/l
427.8
325.7
0.11
133
1087
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
85
1.90
1.55
1.1
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
25
153
1.65
1.54
1.3
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
188
1609
1.21
1.54
4.6
3.5
kg/l
1.0
1.0
0.30
26
210
(3000012) Reticulocyte production index
8
33
2.44
1.54
1.1
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
44
2.29
1.53
1.0
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
41
283
1.47
1.52
11.6
9.6
mmol/l
24.0
24.3
0.38
41
267
(3042733) HLA Ab [Presence] in Serum
5
15
3.35
1.52
6.4
2.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
15
3.35
1.52
1.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
15
3.35
1.52
13.0
9.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
124
1.71
1.48
1.2
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
37
2.45
1.48
1.7
2.9
u/ml
560.8
610.6
—
9
37
(3020891) Body temperature
32
211
1.54
1.47
13.4
4.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
109
1.76
1.47
1.6
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
52
2.13
1.45
1.2
1.4
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
16
3.14
1.44
1.0
1.0
mg/g
6.5
6.1
—
5
16
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
66
1.98
1.44
1.0
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
39
2.32
1.43
3.0
2.4
umol/l
31.3
28.1
—
9
39
(3009214) Lutropin [Units/volume] in Serum or Plasma
41
288
1.44
1.41
1.6
1.4
u/l
13.5
9.7
0.53
31
232
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
29
2.42
1.39
1.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
112
1.71
1.36
2.5
2.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
10
47
2.14
1.34
1.0
1.5
%
36.2
35.8
—
5
30
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
90
1.79
1.33
1.6
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
49
360
1.38
1.33
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
61
1.98
1.33
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
122
1016
1.23
1.32
1.5
1.7
%
1.5
1.4
0.60
103
924
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
83
1.82
1.32
1.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
17
98
1.75
1.31
1.1
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
16
91
1.77
1.29
1.3
1.5
—
16.6
—
0
5
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
62
1.95
1.28
1.2
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
62
1.95
1.28
3.6
1.6
—
—
—
0
0
(4027681)
12
62
1.95
1.28
1.1
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
84
1.80
1.27
1.1
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
26
170
1.54
1.27
17.7
4.2
mmol/l
3.8
3.8
0.06
26
155
(3013139) Helicobacter pylori Ag [Presence] in Stool
66
513
1.31
1.26
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
65
505
1.31
1.24
1.3
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
25
2.41
1.24
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
70
1.87
1.24
1.2
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
35
246
1.44
1.23
1.4
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
49
2.05
1.22
1.4
2.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
44
323
1.38
1.22
2.7
2.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
734
7088
1.18
1.22
4.4
3.9
mmol/l
5.8
5.8
0.42
672
6585
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
19
2.64
1.21
3.4
5.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
684
6570
1.16
1.20
5.6
4.9
mmol/mol
38.7
38.7
0.03
628
6211
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
171
1486
1.19
1.20
2.2
2.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
86
1.76
1.19
1.1
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
26
2.32
1.19
1.5
1.5
ug/l
10.5
8.2
—
6
26
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
6
26
2.32
1.19
1.0
1.1
nmol/l
90.2
101.9
—
6
20
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
141
1.57
1.18
1.3
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
57
1.94
1.17
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
87
1.74
1.15
1.1
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
87
1.74
1.15
1.1
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
118
1.62
1.15
3.3
6.1
—
—
—
0
0
(4035726)
72
575
1.27
1.14
1.4
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
242
1.42
1.13
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
51
1.97
1.11
2.0
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
36
260
1.40
1.11
1.2
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
87
714
1.24
1.10
1.2
1.2
iu/ml
177.4
150.9
0.22
33
294
(3011288) Drugs identified in Urine by Screen method
42
314
1.35
1.06
1.7
2.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
82
1.72
1.05
3.2
1.9
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
90
1.68
1.04
1.2
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
22
2.28
1.03
1.2
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
34
247
1.39
1.03
1.2
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
10
53
1.90
1.01
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
48
1.88
1.00
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
48
1.88
1.00
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
48
1.88
1.00
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
107
1.60
1.00
1.5
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
24
164
1.48
1.00
1.6
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
71
577
1.25
0.99
2.8
4.2
ug/l
3.0
39.2
1.51
49
466
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
241
1.38
0.98
1.2
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
15
92
1.64
0.97
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
108
1.58
0.97
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
751
7305
1.16
0.94
19.5
12.5
%
40.0
39.9
0.23
596
5799
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
62
1.78
0.94
1.2
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
62
1.78
0.94
1.1
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
62
1.78
0.94
1.1
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
159
1.46
0.92
1.5
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
71
1.70
0.89
2.2
2.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
14
87
1.62
0.88
1.1
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
30
2.01
0.87
1.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
30
2.01
0.87
1.2
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
30
2.01
0.87
2.0
4.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
72
1.68
0.85
4.6
3.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
36
274
1.33
0.85
2.5
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
23
162
1.43
0.85
1.1
1.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
15
96
1.57
0.84
3.3
5.1
%
60.7
63.4
0.16
15
96
(3037121) Protein [Mass/volume] in Urine
33
248
1.34
0.84
5.8
3.7
g/l
0.3
0.3
0.09
16
106
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
45
1.78
0.84
1.1
1.6
—
—
—
0
0
(4281824)
11
65
1.70
0.82
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
81
1.61
0.81
1.2
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
13
81
1.61
0.81
1.9
2.8
—
—
—
0
0
(4094501)
23
164
1.41
0.80
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
150
1337
1.15
0.79
2.2
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
33
1.82
0.79
1.5
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
33
1.82
0.79
1.5
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
48
1.67
0.79
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
17
115
1.49
0.77
1.5
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
34
1.77
0.76
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
161
0.62
0.75
4.0
3.9
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
9
53
1.70
0.75
1.1
1.1
—
43.2
—
0
5
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
9
54
1.67
0.74
1.1
1.1
—
61.9
—
0
8
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
54
1.67
0.74
1.1
1.5
ug/l
7.5
6.3
—
9
46
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
159
1.39
0.73
1.1
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
25
2.01
0.72
1.4
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
60
1.67
0.72
1.3
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
5
26
1.93
0.70
1.2
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
26
1.93
0.70
1.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
87
752
1.17
0.70
6.5
6.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
72
613
1.19
0.69
1.5
1.4
iu/l
19.8
25.3
1.07
61
515
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
46
375
1.24
0.68
1.2
1.3
miu/ml
216.3
228.6
0.09
23
192
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
125
1117
1.14
0.65
1.6
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
70
1.58
0.65
1.0
2.0
—
—
—
0
0
(3017704) Immunofixation for Urine
5
29
1.73
0.64
1.4
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
34
270
1.27
0.63
2.8
3.7
%
1.4
1.2
0.49
34
270
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
63
1.59
0.62
1.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
63
1.59
0.62
1.6
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
63
1.59
0.62
1.6
1.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
24
182
1.33
0.62
1.8
1.5
nmol/l
0.3
0.4
0.34
19
150
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
81
706
1.16
0.61
2.1
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
72
1.53
0.59
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
106
1.42
0.58
1.3
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
106
1.42
0.58
1.2
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
35
1.72
0.57
1.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
39
320
1.23
0.56
1.5
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
31
248
1.26
0.56
2.5
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
21
159
1.33
0.55
1.8
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
23
177
1.31
0.55
2.8
2.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
30
240
1.26
0.54
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
101
904
1.13
0.54
2.2
1.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
39
1.54
0.53
1.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
63
1.43
0.52
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
63
1.43
0.52
1.3
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
65
1.39
0.50
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
13
179
0.72
0.50
2.5
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
109
988
1.12
0.48
2.0
1.9
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
22
172
1.29
0.48
3.0
2.6
umol/l
6.1
6.9
0.16
17
126
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
47
1.49
0.47
1.0
1.0
—
—
—
0
0
(4146454)
7
47
1.49
0.47
2.3
2.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
47
1.49
0.47
1.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
47
1.49
0.47
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
38
319
1.20
0.46
9.0
4.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
150
1388
1.10
0.46
1.9
1.7
pmol/l
472.7
28109884.8
1.57
123
1206
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
50
1.40
0.45
1.4
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
7
51
1.38
0.44
1.6
1.5
g/l
26.1
32.2
—
7
44
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
51
1.38
0.44
1.1
2.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
113
1.33
0.43
1.4
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
56
1.43
0.42
2.0
1.7
g/l
0.9
1.0
—
8
56
(3045142) Bone marrow Pathology biopsy report
8
56
1.43
0.42
1.9
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
5
32
1.57
0.42
33.4
25.7
ug/l
6.6
6.9
—
5
27
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
70
1.43
0.42
1.5
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
96
1.36
0.41
1.3
1.3
nmol/l
0.6
0.5
1.04
13
91
(4211845)
5
33
1.52
0.41
2.2
2.7
—
—
—
0
0
(3016750) Collection duration of Urine
5
33
1.52
0.41
3.0
2.1
min
492.4
496.9
—
5
22
(3032868) Hemoglobin electrophoresis panel in Blood
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
16
0.00
0.41
0.0
1.8
—
7.6
—
0
11
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
88
1.37
0.40
1.3
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
35
1.43
0.39
1.6
4.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
10
71
1.41
0.39
1.0
1.8
%
43.8
58.1
—
5
47
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
19
0.00
0.39
0.0
1.6
—
25.5
—
0
12
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
19
0.00
0.39
0.0
3.4
—
1.2
—
0
19
(3022621) pH of Urine by Test strip
53
468
1.14
0.38
2.6
2.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
76
838
0.90
0.37
1.5
1.6
—
—
—
0
0
(3000492) Spirometry study
86
785
1.11
0.36
1.6
1.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
9
71
1.27
0.36
1.1
1.1
—
9.6
—
0
22
(1617658) Protocol used for examination of sentinel lymph nodes
5
77
0.65
0.36
1.2
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
42
1.43
0.35
4.3
8.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
85
777
1.10
0.35
4.2
3.9
%
30.1
32.0
0.85
63
558
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
43
377
1.15
0.34
1.7
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
28
237
1.19
0.34
1.2
1.4
pmol/l
133.5
113.3
0.10
28
231
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
199
0.80
0.33
1.1
1.1
u/ml
0.9
7.6
—
9
113
(4024509)
6
46
1.31
0.33
2.7
1.2
—
—
—
0
0
(1002224) Polysomnography panel
43
379
1.14
0.32
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
19
155
1.23
0.32
1.2
1.1
u/ml
0.8
2.5
—
8
79
(3000475) Leukocytes [#/volume] in Synovial fluid
18
146
1.24
0.32
1.3
1.7
e6/l
2432.4
16298.1
—
8
108
(3000764) Benzodiazepines [Presence] in Urine
51
457
1.12
0.31
1.6
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
20
166
1.21
0.30
2.2
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
55
1.27
0.30
1.3
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
32
278
1.16
0.30
5.7
3.8
mmol/l
26.0
25.0
0.87
32
271
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
56
1.25
0.29
1.3
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
56
1.25
0.29
1.4
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
37
326
1.14
0.29
3.0
3.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
39
345
1.14
0.29
1.7
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
51
461
1.11
0.27
1.6
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
69
635
1.09
0.27
2.9
2.7
ug/l
0.7
0.7
0.24
45
388
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
86
1.28
0.26
1.5
1.2
nmol/l
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
51
463
1.11
0.26
1.6
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
76
1.19
0.24
1.1
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
87
1.27
0.24
1.6
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
84
0.71
0.24
1.2
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
31
349
0.88
0.24
1.8
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
132
1256
1.06
0.23
1.8
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
400
0.90
0.23
1.5
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.2
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.2
1.6
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
40
1.25
0.22
3.0
1.8
%
—
77.8
—
0
5
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.2
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.2
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
42
1.19
0.21
2.0
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.1
—
1.3
—
0
5
(44806420)
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.1
—
29.0
—
0
9
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
6.5
—
0
14
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
76
714
1.07
0.20
1.6
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
19
218
0.87
0.19
1.2
1.1
u/ml
0.1
2.3
—
8
94
(3001019) Free T4 and TSH panel - Serum or Plasma
57
611
0.93
0.19
1.7
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
55
513
1.08
0.18
1.1
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
63
1.11
0.17
1.1
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
49
456
1.08
0.17
1.6
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
69
0.72
0.17
1.2
2.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
70
0.71
0.16
1.2
2.6
mmol/l
105.2
106.0
—
5
70
(3041354) Potassium [Moles/volume] in Venous blood
5
70
0.71
0.16
1.2
2.6
mmol/l
4.1
4.0
—
5
70
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
35
381
0.92
0.16
1.5
1.7
mg/l
4.9
4.8
0.02
24
266
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
139
1.15
0.16
3.6
3.8
mg/l
40.9
27.7
—
10
90
(40768793) Breast Pathology biopsy report
19
214
0.89
0.16
1.4
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
17
149
1.14
0.15
1.2
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
79
1.14
0.15
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
81
1.11
0.15
1.0
2.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
30
326
0.92
0.14
1.6
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
23
209
1.10
0.13
2.9
3.1
u/ml
2335.3
1682.1
0.10
18
184
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
15
167
0.90
0.10
1.3
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
47
1.06
0.09
1.8
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
48
1.04
0.09
1.6
1.5
u/field
0.6
5.2
—
5
39
(40768806) Pleura Pathology biopsy report
5
48
1.04
0.09
1.6
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
55
1.09
0.09
2.2
2.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
73
0.82
0.07
2.3
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
57
590
0.96
0.07
1.3
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
81
0.86
0.07
1.6
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
86
882
0.97
0.07
3.8
4.0
%
25.3
21.6
1.04
40
371
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
183
0.93
0.06
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
175
1776
0.98
0.06
1.6
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
22
207
1.06
0.06
1.6
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
298
2951
1.01
0.06
2.7
2.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
30
314
0.95
0.05
1.6
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
139
1.08
0.05
1.7
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
113
1112
1.02
0.04
4.4
4.4
ug/l
1.9
2.2
0.25
100
1005
(3016879) Cocaine [Presence] in Urine
44
427
1.03
0.04
1.5
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
37
358
1.03
0.04
1.6
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
180
1.06
0.04
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
19
180
1.06
0.04
1.1
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
27
260
1.04
0.03
1.7
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
13
138
0.94
0.02
1.2
1.1
iu/ml
166.3
3512.7
—
7
36
(3023511) Choriogonadotropin [Units/volume] in Urine
32
312
1.03
0.02
1.4
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
46
467
0.98
0.01
1.6
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
31
316
0.98
0.00
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
39
384
1.02
0.00
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
38
384
0.99
0.00
1.6
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
30
302
0.99
0.00
1.9
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
42
421
1.00
0.00
1.5
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
113
0.97
0.00
3.1
1.6
pmol/l
133.2
207.6
1.25
11
107
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
201
0.99
0.00
1.8
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
38
383
0.99
0.00
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
39
385
1.01
0.00
1.6
1.4
—
—
—
0
0
(4034850)
23
225
1.02
0.00
7.2
8.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
16
165
0.97
0.00
2.7
1.5
nmol/l
39.7
40.3
0.04
16
160
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.2
—
8.4
—
0
5
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
7.7
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.4
—
3.2
—
0
5
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
1.9
—
0
7
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
33.4
—
0
5
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
60
1.00
0.00
1.2
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.2
—
5.2
—
0
6
(3027456) Digoxin [Moles/volume] in Serum or Plasma
7
74
0.95
0.00
2.6
3.1
nmol/l
0.9
0.7
—
7
54
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
50
1.00
0.00
1.6
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
59
1.02
0.00
3.3
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_COAGDEF and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_COAGDEF | 1.541 [1.28, 1.85] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.136 |
During the follow-up period (1.1.1998 — 31.12.2019), 184 out of 3408 females with D3_COAGDEF died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_COAGDEF | 1.698 [1.39, 2.07] | < 0.001 |
| Birth year | 0.985 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 193 out of 1530 males with D3_COAGDEF died.
Mortality risk
Mortality risk for people of age
years, who have D3_COAGDEF.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.133% | 0.349% |
| 5 | 0.891% | 1.949% |
| 10 | 2.227% | 4.778% |
| 15 | 4.197% | 8.71% |
| 20 | 7.44% | 14.826% |
Relationships between endpoints
↥Index endpoint: D3_COAGDEF – Chronic Coagulation defects
GWS hits: 10
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data